Mounjaro®
Starting from £179.99/mo
Start journey Learn moreExercise on Mounjaro is not compulsory, but the clinical evidence is clear that it meaningfully improves what the medicine can do. Tirzepatide reduces appetite and promotes fat loss; physical activity helps preserve lean muscle while that fat comes off, which shapes the kind of weight loss that lasts. These are prescription-only medicines reviewed by a clinician before they are prescribed, and your prescriber is the right person to help you match activity to your dose and health history. The sections below clear up the biggest myth about movement on Mounjaro and explain what the research actually supports.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the misconception worth correcting first, because it is genuinely common. The logic goes: if the medicine suppresses appetite strongly enough to produce meaningful weight loss, why add the effort of exercise on top? It feels persuasive, but the clinical picture is more nuanced.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, saw participants lose around 20–21% of body weight at the 15mg dose over 72 weeks. Participants in the trial were also advised to follow a reduced-calorie diet and increase activity. The trial was not designed to isolate exercise as a variable, but the protocol reflected the medicine's licensed use: alongside lifestyle changes, not instead of them.
Weight loss achieved through calorie restriction alone (even with a medicine reducing appetite) draws on both fat stores and lean muscle. Resistance exercise in particular signals the body to hold onto muscle while shedding fat. The practical difference is not trivial: two people who lose the same number of kilograms can end up with very different body compositions, and that difference affects energy levels, metabolic rate, and how easily weight stays off once treatment is reviewed. Our Mounjaro overview page has more on how tirzepatide works mechanically, if the underlying biology is useful context here.
So exercise is not optional in the sense that it is irrelevant. It is optional in the sense that no one will police your gym attendance. Whether it is the right question (compulsory or not) is less useful than asking what kind of activity helps most and how much.
The appetite-suppressing effect of tirzepatide is real and often noticeable within the first few weeks. Many people find they eat less without consciously trying. That is an advantage, but it also means total calorie intake falls, and the body becomes more efficient about where it takes energy from. Adequate protein and regular movement (especially any form of resistance work, from body-weight exercises to gym sessions) are the main tools for keeping muscle in the equation.
Cardiovascular exercise brings separate benefits: it supports heart and metabolic health, improves mood and sleep, and can reduce the blood pressure and cholesterol readings that often improve alongside weight loss anyway. NHS guidance on weight management injections notes that medicines for obesity are intended to be used as part of a broader lifestyle programme, not as a replacement for one.
The honest caveat: there is no single trial that has randomised people on tirzepatide to exercise versus no exercise and measured outcomes directly. What we have is the consistent finding from obesity medicine research broadly (that muscle preservation and cardiovascular fitness improve results) plus a licensing condition that explicitly includes increased physical activity. If you want to read more about structuring activity around your treatment, the Mounjaro exercise plan guide covers practical approaches in detail.
One question our prescribers hear regularly is whether exercise timing relative to the injection matters. There is no strong evidence that it does. What tends to matter more is working around the periods when GI side effects are most pronounced, which is often in the days immediately after a new dose begins or after a dose step up.
Common sense applies here: if you are dealing with nausea on day two of a new dose, a gentle walk is more useful than a high-intensity class. As your system adjusts (usually within a week or so) more sustained activity becomes easier. Some people find that starting exercise mid-week, once the initial post-injection settling period has passed, suits them well. It is a bit like planning a big shop or a long walk for Tuesday rather than a Monday, once you know how your week tends to go.
Dehydration is a practical watch-out. GI effects can reduce fluid intake at the same time as exercise increases fluid loss. Drinking enough water before, during and after exercise is straightforward advice, but it becomes more important on this medicine. If you have questions about adjusting activity during a dose increase, that is exactly the kind of detail to raise with your prescriber rather than working around alone. Our detailed guide on Mounjaro and exercise includes more on managing this practically, and the page on whether exercise is required addresses the eligibility and licensing angle directly.
Mobility limitations, joint problems, fatigue and chronic conditions are real. They are also among the reasons many people need support with weight management in the first place. Tirzepatide is licensed for adults who meet the BMI criteria (including those with weight-related conditions that may make exercise harder) and the clinical assessment at consultation takes your full health picture into account.
The evidence on whether Mounjaro produces weight loss without any exercise suggests it can: the appetite and metabolic effects of tirzepatide are not contingent on your running pace. But the results are better with movement, even modest movement, and almost any increase from your current baseline is clinically worthwhile. Walking counts. So does swimming, cycling at low resistance, or chair-based exercise. The goal is not a specific programme; it is building in more movement than before, at a level that is sustainable.
Cost of treatment is a separate question some people weigh up alongside lifestyle changes. The context around recent Mounjaro pricing in the UK is worth reading if that is part of your thinking. And if you are ready to discuss your own circumstances with a prescriber, starting a free consultation is the logical next step — a real clinician reviews your answers the same day, not a form-processing algorithm.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.